Skip to content

Apotheek Bytebier-Van Antwerpen

Active
Private limited companyfounded 1952active for 74 yearsGuido Gezellestraat 10, 2630 Aartselaar, BelgiumKBO/BCE: BE 0403.668.963
Summary

Apotheek Bytebier-Van Antwerpen has been active since 1952 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €258,780. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 90% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Apotheek Bytebier-Van AntwerpenActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
2nd oldest company in Aartselaar, Wholesale and retail trade sector2 sites
Size
≈ €2.3mturnover 2025, estimated
Staff
4.1 FTE
Equity
€1.5m
Profit
€258,780
Turnover estimated from the gross margin
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Parent
RIMKA PHARMA · 99.7%
2025 accounts 29 days early1 of 3 deeds summarised
Why 98raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 5.14, cash €473,441Founded in 1952Equity €1.5m (81.1% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 82% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 81.1% of total assets
Liquidity 78+3
short-term debt 18.8% · cash 26.4%
Profitability 87-2
return on assets 14.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,263 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1%highest value 12-2024: < 0.1%● unchanged vs 11-2024highest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €140,000 on 30-day terms is acceptable
Liquidity ample (current ratio 5.14, compared with 5.96 in 2024, above the usual 1.5; short-term debt: 18.8% and cash: 26.4% of total assets), and 18.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 82% on liquidity, 82% on profitability and 74% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 5.14, cash €473,441
NBB · annual accounts
lowers risk · Founded in 1952
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €1.5m (81.1% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 days early
2024
34 days early
2023
30 days late
2022
30 days late
2021
31 days late
2020
31 days late
2019
55 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 16 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 filed years within 59 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2018 to 2025net €258,780 ▲11.9%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: 2nd oldest company in Aartselaar, Wholesale and retail trade sectorin the Checked rankings No. 2 View
  • Positive: 8 profitable years in a rowprofit 2025: €258,780 8 years View
  • Controlled by RIMKA PHARMA 99.7% View
  • Active since 1952founded 30-03-1952 74 years View

By topic

Financials

Financial year
2025
Total assets
€1.8m
Profit
€258,780
Solvency
81.1%
Total assets▲ 24.9%
Net result
20182025
Go to Financials

Timeline

Events
54
Since
1978
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €1m
  2. 30-08-2024Annual accounts filed
  3. 07-12-2023Resignation: BYTEBIER Ronan (statutory director)
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
30-03-1952
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Apotheek Bytebier-Van Antwerpen

What is the company number of Apotheek Bytebier-Van Antwerpen?
0403.668.963. In Belgium the VAT number is the company number with BE in front: BE 0403.668.963.
Where is Apotheek Bytebier-Van Antwerpen based?
The registered office is at Guido Gezellestraat 10, 2630 Aartselaar.Company details
What does Apotheek Bytebier-Van Antwerpen do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Bytebier-Van Antwerpen?
Private limited company (BV).
When was Apotheek Bytebier-Van Antwerpen founded?
On 30-03-1952.
Is Apotheek Bytebier-Van Antwerpen still active?
Yes, Apotheek Bytebier-Van Antwerpen is an active enterprise in the KBO register.
How many employees does Apotheek Bytebier-Van Antwerpen have?
On average 4.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Bytebier-Van Antwerpen?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek Bytebier-Van Antwerpen profitable?
In financial year 2025, Apotheek Bytebier-Van Antwerpen made a profit of €258,780.
Where can I find the annual accounts of Apotheek Bytebier-Van Antwerpen?
Apotheek Bytebier-Van Antwerpen filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Bytebier-Van Antwerpen due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek Bytebier-Van Antwerpen

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure